APO Research
Talk to an analyst

APO RESEARCH · REPORT

IVD CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global IVD CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026198 pages

Choose your research edition.

Industry ResearchIVD CDMO Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal IVD CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal IVD CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVD CDMO Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal IVD CDMO Market Analysis and Forecast 2026-2032248 pages · $4,950 USD

Market perspective

The global IVD CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IVD CDMO include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut and Erreka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global IVD CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IVD CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IVD CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the IVD CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

IVD CDMO Segment by Company

Hitachi

Canon

TE Connectivity

JEOL

HU Group

DCN DX

Stevanato

Argonaut

Erreka

GBC

Phillips Medisize

AIVD Biotech

Kaishi Biological Technology

Keysmile Biological Technology

Nabai Medical Technology

Hochuen Medical

IVD CDMO Segment by Type

Molecular Diagnosis

Immunodiagnosis

Biochemical Diagnosis

Other

IVD CDMO Segment by Application

Instruments

Consumables

IVD CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVD CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of IVD CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IVD CDMO industry.

Chapter 3: Detailed analysis of IVD CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVD CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IVD CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Molecular Diagnosis Table 3. Key Players of Immunodiagnosis Table 4. Key Players of Biochemical Diagnosis Table 3. Key Players of Other Table 4. Global IVD CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Instruments Table 6. Key Players of Consumables Table 7. Global IVD CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global IVD CDMO Market Size by Region (2021-2026) & (US$ Million) Table 9. Global IVD CDMO Market Share by Region (2021-2026) Table 10. Global IVD CDMO Market Size by Region (2027-2032) & (US$ Million) Table 11. Global IVD CDMO Market Share by Region (2027-2032) Table 12. IVD CDMO Industry Trends Table 13. IVD CDMO Industry Drivers Table 14. IVD CDMO Industry Opportunities and Challenges Table 15. IVD CDMO Industry Restraints Table 16. Global IVD CDMO Revenue by Company (US$ Million) & (2021-2026) Table 17. Global IVD CDMO Revenue Market Share by Company (2021-2026) Table 18. Global IVD CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global IVD CDMO Key Company Head Office and Area Served Table 20. Global IVD CDMO Company, Product Type & Application Table 21. Global IVD CDMO Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global IVD CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global IVD CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 26. Global IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 27. Global IVD CDMO Revenue Market Share by Type (2021-2026) Table 28. Global IVD CDMO Revenue Market Share by Type (2027-2032) Table 29. Global IVD CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 31. Global IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 32. Global IVD CDMO Revenue Market Share by Application (2021-2026) Table 33. Global IVD CDMO Revenue Market Share by Application (2027-2032) Table 34. Hitachi Company Information Table 35. Hitachi Business Overview Table 36. Hitachi IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Hitachi IVD CDMO Product Portfolio Table 38. Hitachi Recent Development Table 39. Canon Company Information Table 40. Canon Business Overview Table 41. Canon IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Canon IVD CDMO Product Portfolio Table 43. Canon Recent Development Table 44. TE Connectivity Company Information Table 45. TE Connectivity Business Overview Table 46. TE Connectivity IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. TE Connectivity IVD CDMO Product Portfolio Table 48. TE Connectivity Recent Development Table 49. JEOL Company Information Table 50. JEOL Business Overview Table 51. JEOL IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. JEOL IVD CDMO Product Portfolio Table 53. JEOL Recent Development Table 54. HU Group Company Information Table 55. HU Group Business Overview Table 56. HU Group IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. HU Group IVD CDMO Product Portfolio Table 58. HU Group Recent Development Table 59. DCN DX Company Information Table 60. DCN DX Business Overview Table 61. DCN DX IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. DCN DX IVD CDMO Product Portfolio Table 63. DCN DX Recent Development Table 64. Stevanato Company Information Table 65. Stevanato Business Overview Table 66. Stevanato IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Stevanato IVD CDMO Product Portfolio Table 68. Stevanato Recent Development Table 69. Argonaut Company Information Table 70. Argonaut Business Overview Table 71. Argonaut IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Argonaut IVD CDMO Product Portfolio Table 73. Argonaut Recent Development Table 74. Erreka Company Information Table 75. Erreka Business Overview Table 76. Erreka IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Erreka IVD CDMO Product Portfolio Table 78. Erreka Recent Development Table 79. GBC Company Information Table 80. GBC Business Overview Table 81. GBC IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. GBC IVD CDMO Product Portfolio Table 83. GBC Recent Development Table 84. Phillips Medisize Company Information Table 85. Phillips Medisize Business Overview Table 86. Phillips Medisize IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Phillips Medisize IVD CDMO Product Portfolio Table 88. Phillips Medisize Recent Development Table 89. AIVD Biotech Company Information Table 90. AIVD Biotech Business Overview Table 91. AIVD Biotech IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. AIVD Biotech IVD CDMO Product Portfolio Table 93. AIVD Biotech Recent Development Table 94. Kaishi Biological Technology Company Information Table 95. Kaishi Biological Technology Business Overview Table 96. Kaishi Biological Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Kaishi Biological Technology IVD CDMO Product Portfolio Table 98. Kaishi Biological Technology Recent Development Table 99. Keysmile Biological Technology Company Information Table 100. Keysmile Biological Technology Business Overview Table 101. Keysmile Biological Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Keysmile Biological Technology IVD CDMO Product Portfolio Table 103. Keysmile Biological Technology Recent Development Table 104. Nabai Medical Technology Company Information Table 105. Nabai Medical Technology Business Overview Table 106. Nabai Medical Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Nabai Medical Technology IVD CDMO Product Portfolio Table 108. Nabai Medical Technology Recent Development Table 109. Hochuen Medical Company Information Table 110. Hochuen Medical Business Overview Table 111. Hochuen Medical IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Hochuen Medical IVD CDMO Product Portfolio Table 113. Hochuen Medical Recent Development Table 114. North America IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 115. North America IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 116. North America IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 117. North America IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 118. North America IVD CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America IVD CDMO Market Size by Country (2021-2026) Table 120. North America IVD CDMO Market Size by Country (2027-2032) Table 121. Europe IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe IVD CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe IVD CDMO Market Size by Country (2021-2026) Table 127. Europe IVD CDMO Market Size by Country (2027-2032) Table 128. China IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 129. China IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 130. China IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 131. China IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia IVD CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia IVD CDMO Market Size by Country (2021-2026) Table 138. Asia IVD CDMO Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa IVD CDMO Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa IVD CDMO Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa IVD CDMO Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa IVD CDMO Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa IVD CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa IVD CDMO Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa IVD CDMO Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. IVD CDMO Product Image Figure 2. Global IVD CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global IVD CDMO Market Share by Type: 2025 VS 2032 Figure 4. Molecular Diagnosis Image Figure 5. Immunodiagnosis Image Figure 6. Biochemical Diagnosis Image Figure 7. Other Image Figure 8. Global IVD CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global IVD CDMO Market Share by Application: 2025 VS 2032 Figure 10. Instruments Image Figure 11. Consumables Image Figure 12. Global IVD CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global IVD CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global IVD CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 IVD CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global IVD CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global IVD CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global IVD CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global IVD CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America IVD CDMO Market Share by Type (2021-2032) Figure 25. North America IVD CDMO Market Share by Application (2021-2032) Figure 26. North America IVD CDMO Market Share by Country (2021-2032) Figure 27. United States IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe IVD CDMO Market Share by Type (2021-2032) Figure 32. Europe IVD CDMO Market Share by Application (2021-2032) Figure 33. Europe IVD CDMO Market Share by Country (2021-2032) Figure 34. Germany IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China IVD CDMO Market Share by Type (2021-2032) Figure 42. China IVD CDMO Market Share by Application (2021-2032) Figure 43. Asia IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia IVD CDMO Market Share by Type (2021-2032) Figure 45. Asia IVD CDMO Market Share by Application (2021-2032) Figure 46. Asia IVD CDMO Market Share by Country (2021-2032) Figure 47. Japan IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa IVD CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa IVD CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa IVD CDMO Market Share by Country (2021-2032) Figure 57. Brazil IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Diagnosis
  • Immunodiagnosis
  • Biochemical Diagnosis
  • Other
Applications
  • Instruments
  • Consumables
Companies covered
  • Hitachi
  • Canon
  • TE Connectivity
  • JEOL
  • HU Group
  • DCN DX
  • Stevanato
  • Argonaut
  • Erreka
  • GBC
  • Phillips Medisize
  • AIVD Biotech
  • Kaishi Biological Technology
  • Keysmile Biological Technology
  • Nabai Medical Technology
  • Hochuen Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global IVD CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Molecular Diagnosis
  5. 1.2.3 Immunodiagnosis
  6. 1.2.4 Biochemical Diagnosis
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global IVD CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Instruments
  11. 1.3.3 Consumables
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global IVD CDMO Growth Trends by Region
  14. 1.5.1 Global IVD CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 IVD CDMO Market Size by Region (2021-2026)
  16. 1.5.3 IVD CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global IVD CDMO Market Dynamics
  1. 2.1 IVD CDMO Industry Trends
  2. 2.2 IVD CDMO Industry Drivers
  3. 2.3 IVD CDMO Industry Opportunities and Challenges
  4. 2.4 IVD CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global IVD CDMO Revenue by Company (2021-2026)
  2. 3.2 Global IVD CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global IVD CDMO Key Company Head office and Area Served
  4. 3.4 Global IVD CDMO Company, Product Type & Application
  5. 3.5 Global IVD CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global IVD CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 IVD CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 IVD CDMO Tier 1, Tier 2, and Tier 3
4 IVD CDMO Market by Type
  1. 4.1 Global IVD CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global IVD CDMO Market Size by Type (2021-2032)
  3. 4.3 Global IVD CDMO Market Size Share by Type (2021-2032)
5 IVD CDMO Market by Application
  1. 5.1 Global IVD CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global IVD CDMO Market Size by Application (2021-2032)
  3. 5.3 Global IVD CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hitachi
  2. 6.1.1 Hitachi Company Information
  3. 6.1.2 Hitachi Business Overview
  4. 6.1.3 Hitachi IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Hitachi IVD CDMO Product Portfolio
  6. 6.1.5 Hitachi Recent Developments
  7. 6.2 Canon
  8. 6.2.1 Canon Company Information
  9. 6.2.2 Canon Business Overview
  10. 6.2.3 Canon IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Canon IVD CDMO Product Portfolio
  12. 6.2.5 Canon Recent Developments
  13. 6.3 TE Connectivity
  14. 6.3.1 TE Connectivity Company Information
  15. 6.3.2 TE Connectivity Business Overview
  16. 6.3.3 TE Connectivity IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 TE Connectivity IVD CDMO Product Portfolio
  18. 6.3.5 TE Connectivity Recent Developments
  19. 6.4 JEOL
  20. 6.4.1 JEOL Company Information
  21. 6.4.2 JEOL Business Overview
  22. 6.4.3 JEOL IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 JEOL IVD CDMO Product Portfolio
  24. 6.4.5 JEOL Recent Developments
  25. 6.5 HU Group
  26. 6.5.1 HU Group Company Information
  27. 6.5.2 HU Group Business Overview
  28. 6.5.3 HU Group IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 HU Group IVD CDMO Product Portfolio
  30. 6.5.5 HU Group Recent Developments
  31. 6.6 DCN DX
  32. 6.6.1 DCN DX Company Information
  33. 6.6.2 DCN DX Business Overview
  34. 6.6.3 DCN DX IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 DCN DX IVD CDMO Product Portfolio
  36. 6.6.5 DCN DX Recent Developments
  37. 6.7 Stevanato
  38. 6.7.1 Stevanato Company Information
  39. 6.7.2 Stevanato Business Overview
  40. 6.7.3 Stevanato IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Stevanato IVD CDMO Product Portfolio
  42. 6.7.5 Stevanato Recent Developments
  43. 6.8 Argonaut
  44. 6.8.1 Argonaut Company Information
  45. 6.8.2 Argonaut Business Overview
  46. 6.8.3 Argonaut IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Argonaut IVD CDMO Product Portfolio
  48. 6.8.5 Argonaut Recent Developments
  49. 6.9 Erreka
  50. 6.9.1 Erreka Company Information
  51. 6.9.2 Erreka Business Overview
  52. 6.9.3 Erreka IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Erreka IVD CDMO Product Portfolio
  54. 6.9.5 Erreka Recent Developments
  55. 6.10 GBC
  56. 6.10.1 GBC Company Information
  57. 6.10.2 GBC Business Overview
  58. 6.10.3 GBC IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GBC IVD CDMO Product Portfolio
  60. 6.10.5 GBC Recent Developments
  61. 6.11 Phillips Medisize
  62. 6.11.1 Phillips Medisize Company Information
  63. 6.11.2 Phillips Medisize Business Overview
  64. 6.11.3 Phillips Medisize IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Phillips Medisize IVD CDMO Product Portfolio
  66. 6.11.5 Phillips Medisize Recent Developments
  67. 6.12 AIVD Biotech
  68. 6.12.1 AIVD Biotech Company Information
  69. 6.12.2 AIVD Biotech Business Overview
  70. 6.12.3 AIVD Biotech IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AIVD Biotech IVD CDMO Product Portfolio
  72. 6.12.5 AIVD Biotech Recent Developments
  73. 6.13 Kaishi Biological Technology
  74. 6.13.1 Kaishi Biological Technology Company Information
  75. 6.13.2 Kaishi Biological Technology Business Overview
  76. 6.13.3 Kaishi Biological Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Kaishi Biological Technology IVD CDMO Product Portfolio
  78. 6.13.5 Kaishi Biological Technology Recent Developments
  79. 6.14 Keysmile Biological Technology
  80. 6.14.1 Keysmile Biological Technology Company Information
  81. 6.14.2 Keysmile Biological Technology Business Overview
  82. 6.14.3 Keysmile Biological Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Keysmile Biological Technology IVD CDMO Product Portfolio
  84. 6.14.5 Keysmile Biological Technology Recent Developments
  85. 6.15 Nabai Medical Technology
  86. 6.15.1 Nabai Medical Technology Company Information
  87. 6.15.2 Nabai Medical Technology Business Overview
  88. 6.15.3 Nabai Medical Technology IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Nabai Medical Technology IVD CDMO Product Portfolio
  90. 6.15.5 Nabai Medical Technology Recent Developments
  91. 6.16 Hochuen Medical
  92. 6.16.1 Hochuen Medical Company Information
  93. 6.16.2 Hochuen Medical Business Overview
  94. 6.16.3 Hochuen Medical IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Hochuen Medical IVD CDMO Product Portfolio
  96. 6.16.5 Hochuen Medical Recent Developments
7 North America
  1. 7.1 North America IVD CDMO Market Size (2021-2032)
  2. 7.2 North America IVD CDMO Market Size by Type
  3. 7.2.1 North America IVD CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America IVD CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America IVD CDMO Market Share by Type (2021-2032)
  6. 7.3 North America IVD CDMO Market Size by Application
  7. 7.3.1 North America IVD CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America IVD CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America IVD CDMO Market Share by Application (2021-2032)
  10. 7.4 North America IVD CDMO Market Size by Country
  11. 7.4.1 North America IVD CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America IVD CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America IVD CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America IVD CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe IVD CDMO Market Size (2021-2032)
  2. 8.2 Europe IVD CDMO Market Size by Type
  3. 8.2.1 Europe IVD CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe IVD CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe IVD CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe IVD CDMO Market Size by Application
  7. 8.3.1 Europe IVD CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe IVD CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe IVD CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe IVD CDMO Market Size by Country
  11. 8.4.1 Europe IVD CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe IVD CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe IVD CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe IVD CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China IVD CDMO Market Size (2021-2032)
  2. 9.2 China IVD CDMO Market Size by Type
  3. 9.2.1 China IVD CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China IVD CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China IVD CDMO Market Share by Type (2021-2032)
  6. 9.3 China IVD CDMO Market Size by Application
  7. 9.3.1 China IVD CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China IVD CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China IVD CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia IVD CDMO Market Size (2021-2032)
  2. 10.2 Asia IVD CDMO Market Size by Type
  3. 10.2.1 Asia IVD CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia IVD CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia IVD CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia IVD CDMO Market Size by Application
  7. 10.3.1 Asia IVD CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia IVD CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia IVD CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia IVD CDMO Market Size by Country
  11. 10.4.1 Asia IVD CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia IVD CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia IVD CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia IVD CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa IVD CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa IVD CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa IVD CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa IVD CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa IVD CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa IVD CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa IVD CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa IVD CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa IVD CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa IVD CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa IVD CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa IVD CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa IVD CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa IVD CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst